COVID-19 Vaccine Acceptance and Hesitancy among University Community members in Otukpo, Nigeria: A Cross-Sectional Study

Author:

Zakari Suleiman1,Ogbu Celestine O.1,Zakari Hajara1,Chioma Eze Sabina1,Ijimbili Samuel Bawa1,Idoko Jennifer Ene1,Emmanuel Andrew Oche1,Nnenna Amuji Doris2,Agwara Bright Chiaka3,Adokiye Efere Sarah3,Idowu Ayodeji Oluwafemi1,Edegbene Ovie Augustine1,Anejo-Okopi Joseph1

Affiliation:

1. Federal University of Health Sciences

2. Covenant University

3. National Open University of Nigeria

Abstract

Abstract Coronavirus disease (COVID-19) is a global public health problem that has had a detrimental influence on the economy of countries of the world, including Nigeria: (1) Background: The study assessed the level of COVID-19 vaccine acceptance, hesitancy and its associated factors among staff and students of Federal University of Health Sciences Otukpo, Benue State, Nigeria; (2) Methods: The web-based cross-sectional survey was conducted between November 2021 and April 2022. The data was collected and analysed using descriptive and inferential statistics; (3) Results: Of the hundred and fifty (150) completed and analysed questionnaires the mean age of the respondents was 34.8 ± 8.64 years, of which majority of them 80.0% (122) ranging between 16 and 45 years. The majority of the respondents 77.3% (116) have been tested for the virus to know their status. In total, 51.2% of trial participants indicated hesitancy to get the COVID-19 vaccine. The two most frequent reasons for hesitation were scepticism about the vaccination due to fast production and rollout (32.2%) and fear of vaccine side effects due to social media movements (23.3%). The most often cited reasons for not receiving the COVID-19 vaccination included uncertainty about its efficacy, a lack of knowledge about the vaccine, a preference for another kind of protection, and unreliability of the vaccine (due to its rapid development). Staff category (Academics, non-academics, students, and health workers), age, and religion were the significant associated factors influencing vaccine acceptance and hesitancy (P < 0.05); (4) Conclusions: The university community has a high level of awareness of COVID-19 pandemic but vaccine acceptance is low resulting high levels of vaccine hesitancy. These findings suggest that there is a need for further information and education on the COVID-19 vaccine, particularly in communities where vaccine hesitancy is prevalent. This can be achieved through targeted outreach programs, community engagement initiatives, and effective communication strategies that address the concerns and questions of individuals who are hesitant about receiving the vaccine.

Publisher

Research Square Platform LLC

Reference44 articles.

1. The novel coronavirus outbreak in Wuhan, China;Zhu H;Glob Health Res Policy,2020

2. CDC. Basics of COVID-19. Center for disease control and prevention. 2021 [cited 2021 Jan 12]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19/basics-covid-19.html

3. Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study;Hanna P;J of Pharm Policy and Pract.,2022

4. WHO. Coronavirus disease (COVID-19) [Internet]. Coronavirus disease (COVID-19) pandemic. 2021 [cited 2021 Jan 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=CjwKCAjw6IiiBhAOEiwALNqncQzxt9lOFSQ_yUNnYCf4XFPxqiTsXkz3Bej34UV0IVUbEKUKmvMrzxoCznoQAvD_BwE.

5. WHO. Coronavirus disease (COVID-19) [Internet]. World Health Orgaanization. 2023 [cited 2023 Apr 21]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3